IL-17 Pathway Members as Potential Biomarkers of Effective Systemic Treatment and Cardiovascular Disease in Patients with Moderate-to-Severe Psoriasis.

Wang, Xing; Kaiser, Hannah; Kvist-Hansen, Amanda; McCauley, Benjamin D; Skov, Lone; Hansen, Peter Riis; Becker, Christine

Wang, Xing; Kaiser, Hannah; Kvist-Hansen, Amanda; McCauley, Benjamin D; Skov, Lone; Hansen, Peter Riis; Becker, Christine.

Affiliation

Wang X; Department of Medicine, Division of Clinical Immunology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Kaiser H; Department of Cardiology, University Hospital-Herlev and Gentofte, 2900 Hellerup, Denmark.
Kvist-Hansen A; Department of Dermatology and Allergy, University Hospital-Herlev and Gentofte, 2900 Hellerup, Denmark.
McCauley BD; Department of Clinical Medicine, University of Copenhagen, 2200 Copenhagen, Denmark.
Skov L; Department of Cardiology, University Hospital-Herlev and Gentofte, 2900 Hellerup, Denmark.
Hansen PR; Department of Dermatology and Allergy, University Hospital-Herlev and Gentofte, 2900 Hellerup, Denmark.
Becker C; Department of Medicine, Division of Clinical Immunology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Int J Mol Sci ; 23(1)2022 Jan 05.

Article in En | MEDLINE | ID: mdl-35008981

Subject(s)
Key words

IL-17A; IL-17C; Olink; PI3/elafin; cardiovascular disease; proteomics; psoriasis; psoriasis area and severity index

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Biomarkers / Cardiovascular Diseases / Signal Transduction / Interleukin-17 Type of study: Diagnostic_studies / Etiology_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Int J Mol Sci Year: 2022 Document type: Article Affiliation country: Estados Unidos Country of publication: Suiza

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google